Overview
- Dr Martens, which reported full-year results Tuesday, said adjusted pre-tax profit rose 61% to £55 million.
- Statutory pre-tax profit reached £32.7 million, a 270% jump driven by lower supply-chain costs, including cheaper ocean freight.
- Revenue slipped to £764.9 million in line with guidance as the company cut discounting and focused on full-price sales, with shoe sales up 19%.
- The Americas showed the strongest recovery, while Europe and the Middle East fell 1.7% and Asia Pacific declined 5.1%.
- Leaders kept the dividend, set plans to invest in the brand and stores to scale in FY27, and warned that trading remains unpredictable.